Segall Bryant & Hamill, LLC Novartis Ag Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $689,350 - $765,031	-7,277 Reduced 4.84%	142,929 $14.6 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $271,268 - $307,596	-2,932 Reduced 1.91%	150,206 $15.2 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $398,629 - $462,286	-4,981 Reduced 3.15%	153,138 $14.1 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $11.9 Million - $14.6 Million	158,119 New	158,119 $14.3 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $13.2 Million - $15.5 Million	177,453 New	177,453 $13.5 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $378,041 - $440,156	-4,695 Reduced 2.53%	180,548 $15.3 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $14.8 Million - $16.8 Million	185,243 New	185,243 $16.3 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $18.2 Million - $20.1 Million	-227,872 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$81.78 - $95.14 $3.01 Million - $3.5 Million	-36,809 Reduced 13.91%	227,872 $18.6 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $2.2 Million - $2.43 Million	-25,786 Reduced 8.88%	264,681 $24.1 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $6.81 Million - $8.03 Million	-81,537 Reduced 21.92%	290,467 $24.8 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $15.7 Million - $19 Million	-201,023 Reduced 35.08%	372,004 $35.1 Million
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $1.69 Million - $1.87 Million	20,539 Added 3.72%	573,027 $49.8 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $1.99 Million - $2.24 Million	24,596 Added 4.66%	552,488 $48.3 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $445,291 - $623,862	6,301 Added 1.21%	527,892 $43.5 Million
Q4 2019 Feb 11, 2020	SELL	$84.35 - $95.37 $29,269 - $33,093	-347 Reduced 0.07%	521,591 $49.4 Million
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $1.91 Million - $2.1 Million	22,282 Added 4.46%	521,938 $45.4 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $2.18 Million - $2.69 Million	28,969 Added 6.15%	499,656 $0
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $6.55 Million - $7.5 Million	87,024 Added 22.68%	470,687 $0
Q4 2018 Feb 15, 2019	BUY	$73.66 - $82.02 $23.1 Million - $25.7 Million	312,989 Added 442.86%	383,663 $29.5 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $154,631 - $178,863	-2,310 Reduced 3.17%	70,674 $0
Q2 2018 Aug 08, 2018	BUY	$64.91 - $73.36 $1.67 Million - $1.89 Million	25,741 Added 54.49%	72,984 $0
Q1 2018 May 16, 2018	SELL	$70.39 - $84.15 $192,305 - $229,897	-2,732 Reduced 5.47%	47,243 $0
Q4 2017 Feb 15, 2018	BUY	$72.33 - $77.64 $216 - $232	3 Added 0.01%	49,975 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $3.7 Million - $3.86 Million	49,972	49,972 $0

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account